SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL), a leading provider of point-of-care (POC) rapid diagnostic tests, today announced that its Board of Directors has authorized the Company to repurchase up to an additional $25 million in shares of its common stock. This is in addition to the remaining amounts authorized under the Company's May 2005 $25 million repurchase program. This increased authorization also extends the Company’s share repurchase program to March 9, 2009. Under the share repurchase program, shares of the Company's common stock may be repurchased from time to time in both privately negotiated and open market transactions, including pursuant to a 10b5-1 plan, subject to management’s evaluation of market conditions, applicable legal requirements and other factors.
